Jul. 14 at 5:04 PM
$UNH plunges 39.9% YTD — is it time to reassess? 📉
Despite a solid commercial segment, UNH faces regulatory challenges and a Zacks Rank #5 (Strong Sell) amidst a broader industry decline. The stock's valuation is above the industry average, with a forward P/E of 12.85, and guidance has been pulled back due to ongoing pressures.
Competitors like
$MOH and
$CI are also navigating challenges.
Full analysis here 👉 https://www.zacks.com/stock/news/2580332/unitedhealths-commercial-unit-a-stabilizer-amid-healthcare-turmoil?cid=sm-stocktwits-2-2580332-body-1663&ADID=SYND_STOCKTWITS_TWEET_2_2580332_BODY_1663